Scicon-MR update – 90mg strength
Gliclazide
THERAPEUTIC SEGMENT:
Oral Antidiabetic
INDICATIONS:
Type 2 diabetes mellitus.
BRIEF DESCRIPTION:
Scicon-MR 90mg (Gliclazide) is an oral antidiabetic agent containing a modified-release version of the active ingredient Gliclazide. Scicon-MR 90mg belongs to a class of oral hypoglycemic agents known as sulphonylureas and is used to help control blood glucose levels in patients with Type 2 diabetes.
DOSAGE FORM:
Tablets
30mg
60mg
90mg
Disclaimer: For use under medical prescription only
Reviews
There are no reviews yet.